Study: Abbott blood test spots more female heart attack risks

An Abbott ($ABT) Diagnostics assay wowed researchers by identifying many more female patients likely to suffer heart attacks than current technology allows. As The Telegraph reports, the test measures levels of troponin, a protein that leaks into the blood from heart muscle cells after a heart attack. Current tests do this, but they are far less sensitive. That's relevant to female cardiac patients because women generate lower troponin levels in general, according to the article, and doctors had previously assumed that troponin levels indicating a heart attack were equal in male and female patients. This new test showed otherwise, researchers from the University of Edinburgh and colleagues noted as part of the European Society of Cardiology conference in Amsterdam. The hope is that the diagnostic will help boost correct heart attack diagnoses for women and improve treatment and outcomes. Story

Suggested Articles

Dexcom received a new European approval for its wearable continuous glucose monitor in pregnant women across Type 1, Type 2 and gestational diabetes.

Infectious disease blood tester Karius has raised $165 million led by SoftBank’s Vision Fund 2, the Japanese conglomerate’s sequel to its VC megafund.

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.